Dynavox Group ABFRA:H3Q +3.05%79 PB Ratio is 9.85 as of Jul. 12, 2026, which is 37% below its 10-year median of 15.57. GuruFocus rates FRA:H3Q with a GF Score™ of 79/100 and a GF Value™ of €7.82 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Dynavox Group AB ranks worse than 91.37% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), Dynavox Group AB's share price is €5.745. Dynavox Group AB's Book Value per Share for the quarter that ended in Mar. 2026 was €0.58. Hence, Dynavox Group AB's PB Ratio of today is 9.85.
Good Sign:
Dynavox Group AB stock PB Ratio (=10.17) is close to 5-year low of 9.25.
The historical rank and industry rank for Dynavox Group AB's PB Ratio or its related term are showing as below:
FRA:H3Q'
s PB Ratio Range Over the Past 10 Years
Min: 9.25 Med: 15.57 Max: 57.2
Current: 10.17
During the past 7 years, Dynavox Group AB's highest PB Ratio was 57.20. The lowest was 9.25. And the median was 15.57.
FRA:H3Q's PB Ratio is ranked worse than 91.37% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs FRA:H3Q: 10.17
During the past 12 months, Dynavox Group AB's average Book Value Per Share Growth Rate was 48.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 41.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 71.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Dynavox Group AB was 116.50% per year. The lowest was 41.60% per year. And the median was 70.55% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Dynavox Group AB PB Ratio Related Terms
Dynavox Group AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Dynavox Group AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Dynavox Group AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynavox Group AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynavox Group AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dynavox Group AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dynavox Group AB (FRA:H3Q) has a PB Ratio of 9.85 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dynavox Group AB and its competitors. This is 37% below median its historical median of 15.57. Over the past decade, Dynavox Group AB's PB Ratio has ranged from 9.25 to 57.20. According to the industry distribution chart, Dynavox Group AB ranks #720 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 91.4%.
Is Dynavox Group AB's PB Ratio too high?
Dynavox Group AB's current PB Ratio of 9.85 is 37% below median its 10-year median of 15.57. Over the past 10 years, this metric has ranged from a low of 9.25 to a high of 57.20. The Medical Devices & Instruments industry median PB Ratio is 2.07. Dynavox Group AB's value of 9.85 is 377% above this industry median. Based on the distribution chart, Dynavox Group AB ranks #720 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Dynavox Group AB has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynavox Group AB's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dynavox Group AB ranks #720 out of 788 companies for PB Ratio. This places Dynavox Group AB in the lower half of its industry. The industry median PB Ratio is 2.07. Dynavox Group AB's value of 9.85 is 377% above this benchmark. Historically, Dynavox Group AB's own PB Ratio has ranged from 9.25 to 57.20 over the past decade. While the company's 10-year median is 15.57 vs. the industry median of 2.07, Dynavox Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynavox Group AB's current PB Ratio of 9.85 is 377% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dynavox Group AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynavox Group AB's current PB Ratio is 9.85, which is 37% below median its own 10-year median of 15.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynavox Group AB stock overvalued right now?
Based on GuruFocus' analysis, Dynavox Group AB (FRA:H3Q) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.82, compared to a current price of €5.75 — trading 26.5% below its estimated fair value. The current PB Ratio is 9.85, which is 37% below median its 10-year median of 15.57 and 377% above the Medical Devices & Instruments industry median of 2.07. Dynavox Group AB's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dynavox Group AB (FRA:H3Q), the current PB Ratio is 9.85 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynavox Group AB (FRA:H3Q) Overvalued in 2026?
Based on GuruFocus' analysis, Dynavox Group AB stock appears to be undervalued.
The current stock price of €5.75 is trading 26.5% below its estimated GF Value™ of €7.82.
GuruFocus considers Dynavox Group AB to be Modestly Undervalued.
Key valuation signals for FRA:H3Q:
PB Ratio: 9.85 (37% below median its 10-year median of 15.57)
GF Value™: €7.82 vs. price of €5.75 (26.5% below fair value)
Industry Position: 377% above the Medical Devices & Instruments median (#720 of 788)
No single metric tells the full story. See the FRA:H3Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynavox Group AB is engaged in assistive technology for communication. The company's Augmentative and Alternative Communication (AAC) solutions enable people with disabilities such as cerebral palsy, ALS, and spinal cord injury to communicate with a voice of their own, develop literacy skills, and live more independently. The company is a comprehensive SaaS provider with local roots. The company operates in Europe, North America, and Other countries, with the majority of revenue from North America.
79GF Score
Get the complete analysis for FRA:H3Q
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:H3Q has been successfully added to your 
